Product NDC: | 49502-501 |
Proprietary Name: | EpiPen Jr |
Non Proprietary Name: | Epinephrine |
Active Ingredient(s): | .15 mg/.3mL & nbsp; Epinephrine |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49502-501 |
Labeler Name: | Dey Pharma L.P. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019430 |
Marketing Category: | NDA |
Start Marketing Date: | 19871222 |
Package NDC: | 49502-501-02 |
Package Description: | 2 CONTAINER in 1 CARTON (49502-501-02) > 1 SYRINGE, GLASS in 1 CONTAINER > .3 mL in 1 SYRINGE, GLASS |
NDC Code | 49502-501-02 |
Proprietary Name | EpiPen Jr |
Package Description | 2 CONTAINER in 1 CARTON (49502-501-02) > 1 SYRINGE, GLASS in 1 CONTAINER > .3 mL in 1 SYRINGE, GLASS |
Product NDC | 49502-501 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Epinephrine |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 19871222 |
Marketing Category Name | NDA |
Labeler Name | Dey Pharma L.P. |
Substance Name | EPINEPHRINE |
Strength Number | .15 |
Strength Unit | mg/.3mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |